Valitor

Valitor is an antibody-drug conjugate (ADC) developer. The company's lead program, VLTR-557, is a highly engineered anti-VEGF antibody conjugate designed to overcome the limitations of established drug targets through multivalent biopolymer technology, thereby maximizing benefits for patients.